PhRMA chairman Ian Read has laid out the U.S. industry association’s views on what’s good and not so good about the pharmaceutical operating environment in Japan. While there is now a much shorter wish list, the group still sees some room for improvement. Read more. (Source: The Pink Sheet, 12/8/14).
You are here: / / PhRMA Sees Good Japan Policy Progress, With Gaps